Compare Globus Medical Inc. Class A Common Stock (GMED) vs Upstart Holdings Inc (UPST) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

Upstart Holdings trades at $23.83, showing modest daily gains of 0.34% but remains in a bearish technical trend. The company reported mixed Q2 2026 earnings with $0.16 EPS missing expectations of $0.18, though revenue growth accelerated to $1.02 billion in 2025 with positive net income of $54 million. Recent news highlights partnership expansions into HELOC and auto lending while the stock faces pressure near 52-week lows.

Despite recent profitability improvements, Upstart faces execution risks with three consecutive earnings misses and negative operating cash flow. Analyst consensus remains divided with a $38.13 price target suggesting 60% upside potential, but high valuation multiples and competitive pressures in consumer lending warrant caution for investors.